人多发性骨髓瘤骨髓细胞外基质的蛋白质组学特征
该研究应用蛋白质组学策略,比较了意义未明的单克隆丙种球蛋白病(MGUS)、新诊断和复发多发性骨髓瘤(MM)患者与健康供者骨髓细胞外基质(ECM)的组成。研究发现,MGUS和MM中肿瘤ECM在mRNA和蛋白质水平发生重塑,形成允许性微环境;ECM相关蛋白ANXA2和LGALS1在MM中更丰富,高表达与总生存期缩短相关。
要点
- MGUS和MM患者的骨髓ECM在mRNA和蛋白质水平发生重塑。
- ECM相关蛋白ANXA2和LGALS1在MM中更丰富。
- ANXA2和LGALS1高表达与总生存期缩短相关。
核心结论
- MM中ECM重塑具有重要意义,并提供了用于研究ECM在具有骨髓趋向性癌症中作用的新型蛋白质组学流程。
研究设计与样本
- 应用新型蛋白质组学策略,比较MGUS、新诊断MM和复发MM患者与健康供者来源的骨髓ECM组成。
主要发现
- 肿瘤ECM在MGUS和MM中于mRNA和蛋白质水平发生重塑,以形成允许性微环境。
- ECM相关蛋白ANXA2和LGALS1在MM中更丰富,高表达与总生存期缩短相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The extracellular matrix (ECM) is a major component of the tumor microenvironment, contributing to the regulation of cell survival, proliferation, differentiation and metastasis. In multiple myeloma (MM), interactions between MM cells and the bone marrow (BM) microenvironment, including the BM ECM, are critical to the pathogenesis of the disease and the development of drug resistance. Nevertheless, composition of the ECM in MM and its role in supporting MM pathogenesis has not been reported. We have applied a novel proteomic-based strategy and defined the BM ECM composition in patients with monoclonal gammopathy of undetermined significance (MGUS), newly diagnosed and relapsed MM compared with healthy donor-derived BM ECM. In this study, we show that the tumor ECM is remodeled at the mRNA and protein levels in MGUS and MM to allow development of a permissive microenvironment. We further demonstrate that two ECM-affiliated proteins, ANXA2 and LGALS1, are more abundant in MM and high expression is associated with a decreased overall survival. This study points to the importance of ECM remodeling in MM and provides a novel proteomic pipeline for interrogating the role of the ECM in cancers with BM tropism.
引用
- Glavey SV, Naba A, Manier S, et al. Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. Leukemia. 2017. PMID: 28344315. doi:10.1038/leu.2017.102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。